These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11535627)

  • 1. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow.
    Keller P; Payne JL; Tremml G; Greer PA; Gaboli M; Pandolfi PP; Bessler M
    J Exp Med; 2001 Sep; 194(5):581-9. PubMed ID: 11535627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA1-Cre mediates Piga gene inactivation in the erythroid/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells).
    Jasinski M; Keller P; Fujiwara Y; Orkin SH; Bessler M
    Blood; 2001 Oct; 98(7):2248-55. PubMed ID: 11568013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation.
    Keller P; Tremml G; Rosti V; Bessler M
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7479-83. PubMed ID: 10377440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene.
    Tremml G; Dominguez C; Rosti V; Zhang Z; Pandolfi PP; Keller P; Bessler M
    Blood; 1999 Nov; 94(9):2945-54. PubMed ID: 10556176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF induced progenitor mobilization in mice with PIGA- blood cells.
    Han B; Unsinger J; Liu F; Link DC; Bessler M
    Hematol J; 2004; 5(4):347-52. PubMed ID: 15297852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of GPI-anchor deficiency on apoptosis in mice carrying a Piga gene mutation in hematopoietic cells.
    Kulkarni S; Bessler M
    J Leukoc Biol; 2002 Dec; 72(6):1228-33. PubMed ID: 12488505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria.
    Murakami Y; Kinoshita T; Maeda Y; Nakano T; Kosaka H; Takeda J
    Blood; 1999 Nov; 94(9):2963-70. PubMed ID: 10556178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria.
    Johnston JJ; Gropman AL; Sapp JC; Teer JK; Martin JM; Liu CF; Yuan X; Ye Z; Cheng L; Brodsky RA; Biesecker LG
    Am J Hum Genet; 2012 Feb; 90(2):295-300. PubMed ID: 22305531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology.
    Bessler M; Schaefer A; Keller P
    Transfus Med Rev; 2001 Oct; 15(4):255-67. PubMed ID: 11668433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Boccuni P; Del Vecchio L; Di Noto R; Rotoli B
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):25-43. PubMed ID: 10714960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SIN lentiviral vector containing PIGA cDNA allows long-term phenotypic correction of CD34+-derived cells from patients with paroxysmal nocturnal hemoglobinuria.
    Robert D; Mahon FX; Richard E; Etienne G; de Verneuil H; Moreau-Gaudry F
    Mol Ther; 2003 Mar; 7(3):304-16. PubMed ID: 12668126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells.
    Visconte V; Raghavachari N; Liu D; Keyvanfar K; Desierto MJ; Chen J; Young NS
    Haematologica; 2010 Feb; 95(2):214-23. PubMed ID: 19679885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymus reconstitution by c-kit-expressing hematopoietic stem cells purified from adult mouse bone marrow.
    de Vries P; Brasel KA; McKenna HJ; Williams DE; Watson JD
    J Exp Med; 1992 Dec; 176(6):1503-9. PubMed ID: 1281208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.
    Georgiades P; Ogilvy S; Duval H; Licence DR; Charnock-Jones DS; Smith SK; Print CG
    Genesis; 2002 Dec; 34(4):251-6. PubMed ID: 12434335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of proinflammatory cytokines on PIGA- hematopoiesis.
    Kulkarni S; Bessler M
    Exp Hematol; 2003 Sep; 31(9):770-8. PubMed ID: 12962722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hiken J
    Hematology Am Soc Hematol Educ Program; 2008; ():104-10. PubMed ID: 19074066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of paroxysmal nocturnal hemoglobinuria].
    Murakami Y
    Rinsho Ketsueki; 2016; 57(10):1900-1907. PubMed ID: 27725586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria in children.
    van den Heuvel-Eibrink MM
    Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutation and clonal selection in the pathogenesis and in the control of paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hillmen P
    Semin Hematol; 1998 Apr; 35(2):149-67. PubMed ID: 9565157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labeling of hematopoietic stem and progenitor cells in novel activatable EGFP reporter mice.
    Gilchrist DS; Ure J; Hook L; Medvinsky A
    Genesis; 2003 Jul; 36(3):168-76. PubMed ID: 12872249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.